We collect cookies to enhance your browsing experience Learn more

Towards Healthcare

Retinal Biologics Market Size (USD 49.67 Bn) Report by 2033

The report covers Retinal Biologics Market Shares and Segments Analysis such as drugs into VEGF-A antagonists and TNF-A inhibitors, targeting conditions like macular degeneration, diabetic retinopathy and uveitis. Distribution channels include hospital, retail and online pharmacies. Geographically North America, Europe, Asia Pacific, Latin America and the Middle East & Africa leads the market. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Retinal Biologics Market Assessment

  • Overview
  • Global Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • VEGF-A Antagonist
    • TNF-A Inhibitor
  • Global Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Macular Degeneration
    • Diabetic Retinopathy
    • Uveitis
    • Others
  • Global Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

North America Retinal Biologics Market Assessment

  • Overview
  • North America Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • VEGF-A Antagonist
    • TNF-A Inhibitor
  • North America Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Macular Degeneration
    • Diabetic Retinopathy
    • Uveitis
    • Others
  • North America Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Europe Retinal Biologics Market Assessment

  • Overview
  • Europe Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • VEGF-A Antagonist
    • TNF-A Inhibitor
  • Europe Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Macular Degeneration
    • Diabetic Retinopathy
    • Uveitis
    • Others
  • Europe Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Asia Pacific Retinal Biologics Market Assessment

  • Overview
  • Asia Pacific Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • VEGF-A Antagonist
    • TNF-A Inhibitor
  • Asia Pacific Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Macular Degeneration
    • Diabetic Retinopathy
    • Uveitis
    • Others
  • Asia Pacific Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Latin America Retinal Biologics Market Assessment

  • Overview
  • Latin America Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • VEGF-A Antagonist
    • TNF-A Inhibitor
  • Latin America Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Macular Degeneration
    • Diabetic Retinopathy
    • Uveitis
    • Others
  • Latin America Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Middle East & Africa Retinal Biologics Market Assessment

  • Overview
  • Middle East & Africa Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • VEGF-A Antagonist
    • TNF-A Inhibitor
  • Middle East & Africa Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Macular Degeneration
    • Diabetic Retinopathy
    • Uveitis
    • Others
  • Middle East & Africa Retinal Biologics Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Company Profiles

  • Santen Pharmaceutical Co., Ltd (Japan)
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • AbbVie Inc. (U.S.)
  • Aurobindo Pharma (India)
  • Bayer AG (Germany)
  • Bayer AG (Germany)
  • Fresenius Kabi AG (Germany)
  • AstraZeneca (U.K.)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Merck & Co Inc. (U.S.)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Amgen Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Kodiak Sciences Inc. (U.S.)

Conclusion & Recommendations

  • Insight Code: 5166
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

The human immune system is able to identify biologics quickly and able to mount a faster immune response.

While drugs are completely synthesized from molecular compounds with the help of chemical reactions, biologics are produced or extracted from biological entities.

FDA, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), National Bureau of Statistics of China, National Library of Medicine, National Institutes of Health.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 465

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 465